Sign in
CompletedNo phase

Supplemental Thiamine in Septic Shock: A Before-after Study

Key facts

Who runs it
Hospital Sao Domingos
Where
Brazil1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
73 people enrolled
Started
1 Sept 2023
Ended
31 Dec 2023
Type of study
Observational, 2 groups
Treatments tested
  • Thiamin
Record updated
18 April 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • age > 18 years
  • presence of documented or suspected infection, SOFA score ≥ 2, serum lactate levels > 18 mg/dL and hypotension, MAP < 65 mm Hg maintained after volume expansion of at least 30 ml/kg in the first 2 hours of treatment followed by noradrenaline vasopressor dependence (with or without vasopressin) during the first 6 hours of treatment

Who cannot take part

  • pregnant women
  • patients treated only with comfort measures

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This controlled before-and-after study analyse the impact of thiamine supplementation on outcomes of patients with septic shock treated according to the surviving sepsis campaign 2021 guidelines

The 2 groups in the trial

  • Control group

    Septic shock patients treated according surviving sepsis campaign 2021 guidelines

  • Intervention group

    Septic shock patients treated according surviving sepsis campaign 2021 guidelines supplemented with thiamin 200 mg in 50 ml 5% dextrose twice daily for 7 days.

    Treatment: Thiamin

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Impact of Thiamine Supplementation on Clinical Outcomes of Patients With Septic Shock: a Retrospective Before-after Study
Record updated
18 April 2024